Tata group design and technology services firm Tata Elxsi is set to stage a strong performance for the December quarter, with ...
Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.
EPAM Systems is a "Buy" given its partnerships, market share gains, and faster revenue growth. Learn more about the company ...
Amer Sports gets a Buy: 30% revenue growth, Arc’teryx/Salomon strength, DTC & women’s upside. Click here to read more.
Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, and Vuzix ® Corporation (NASDAQ: VUZI), ("Vuzix"), a ...
Nomura said it sees Titan as a key beneficiary of the rising affluent and elite income population in India, with sales growth at 1.5-2 times GDP over the medium term.
Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with ...
Friday, June 27, 2025 at 8:30 a.m. ET President and Chief Executive Officer — Paul E. Sternlieb Reported Revenue -- $159 ...
The engine is also extremely powerful, producing 1,000 hp on its own. When combined with an electric motor, the RB17 wades ...
We chat with the art collective known as Puke as they bring chaotic, glorious design to custom MTG and Tabletop accessories.
Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data: Stockholm Friday, January 9, 2026, 11:00 Hrs [IST] Sobi, a global biopharma company, anno ...
The evidence indicates that non-invasive monitoring (near-infrared spectroscopy; NIRS) of oxygen in brain tissue likely does not reduce death rates or short-term brain problems for very premature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results